Navigation Links
AlphaDetail Revenue Soars 30% in 2010
Date:2/10/2011

SAN MATEO, Calif., Feb. 10, 2011 /PRNewswire/ -- AlphaDetail, a leader in global primary market research for the pharmaceutical and biotech industries, reported a 30% increase in revenue in 2010, exceeding $18.5M in annual revenue for the first time in the company's history.

"Our clients have delivered a loud and clear message that AlphaDetail provides the marketing research solutions that get at the heart of their strategic information needs," says Rishi Varma, CEO and President of AlphaDetail. "Our performance in 2010 makes us one of the fastest growing market research companies in the United States."

The company's record performance included major advances across a broad array of clients and product lines. Major contributors to revenue growth include:

  • Global studies increased 120% with strong growth from Emerging Markets
  • Early stage product profile testing and market modeling increased 114% supported by advances in discrete choice techniques
  • ATU / Tracking solutions increased 44% bolstered by portfolio-wide solutions supported by the AlphaMonitor™ web-based portal
  • KOL mapping increased 17% fueled by key new product enhancements that more closely integrate multiple sources of information into a holistic understanding of influence
  • Revenues from the 5 largest clients grew 48% while the company simultaneously broadened its overall client base.

Rishi Varma continued, "We approach AlphaDetail's 10 year anniversary with strong growth, an expanding portfolio of offerings, a world-class team, and the highest client satisfaction scores in the industry."

About AlphaDetail, Inc.:

At AlphaDetail, we have an unparalleled commitment to our clients. We are a full-service primary market research firm, with a particular emphasis in large and complex quantitative studies for the global healthcare community. AlphaDetail is built on one of the industry's strongest foundations that includes a large team of exceptional analytical specialists, the industry's leading technology platform and a flexible approach to research that helps us to answer our client's most challenging questions.


'/>"/>
SOURCE AlphaDetail, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AlphaDetail, Inc. Enhances Methodology / Advanced Analytics Capabilities
2. AlphaDetail Tracking Study Enhancements: The Advantage of Integration and Speed
3. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
4. Solos Endoscopy, Inc. Reports $34,291 in Sales Revenue for January 2011
5. Spectros Corporation Sales and Licensing Revenue Up 32% in 2010
6. Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance
7. Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations
8. Solos Endoscopy, Inc. Reports $90,005 in Sales Revenue for Fourth Quarter 2010
9. Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56
10. Weikang Bio-Technology Expects to Report Fiscal 2010 Revenue of $77.8 Million and Net Income of $31.2 Million or $1.04 Earnings per Share
11. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... 18 months after its February 2016 launch, market access ... of three new senior people to its rapidly expanding ... and James Wright bring decades of specialist ... Tammy Wynne joins as Director, Value Communication, ... over ten years, experience in global market access consultancy ...
(Date:9/1/2017)... 2017  Bayer will present the latest research from across ... Oncology (ESMO) 2017 Congress, September 8-12 in Madrid, ... and clinical data on Bayer,s marketed portfolio and late-stage compounds ... "We value the opportunity ... research at ESMO," said Carsten Brunn , Head of ...
Breaking Medicine Technology:
(Date:9/26/2017)... ... 26, 2017 , ... Global healthcare company Novo Nordisk, renewed ... company’s commitment to the world’s first all-diabetes professional cycling team to a total ... partnered with the professional cycling team Team Type 1 to create Team Novo ...
(Date:9/26/2017)... ... September 26, 2017 , ... After a summer-long contest ... Campaign for Designated Drivers proudly announced the winners of the HEROtini Mocktail Challenge ... restaurants took on the challenge of competing in three categories: Best HEROtini Mocktail, ...
(Date:9/26/2017)... ... September 26, 2017 , ... ... expands services in Northern Colorado. Aspire Autism, A Division of Autism Learning Partners, ... Analysis (ABA) services. Aspire provides center based Autism services in Broomfield and will ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Good Morning Sunshine!: Finding Strength and Comfort ... “Good Morning Sunshine!: Finding Strength and Comfort in God” is the creation of published ... Hays Sate University, who has worked at a local mental health center for over ...
(Date:9/26/2017)... ... , ... “The Tour Guide”: is the life story of the author and the exciting times ... Alexander Stark, is an adventure tour guide and the subject of the book. , ... confront fifteen shocked faces. I played it off as a part of the adventure tour, ...
Breaking Medicine News(10 mins):